Skip to main content
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. — Investor Relations & Filings

Ticker · SLS ISIN · US81642T2096 LEI · 549300VZIH50VYURLQ98 US Manufacturing
Open in API
Filings indexed 1,071 across all filing types
Latest filing 2012-03-28 Regulatory Filings
Country US United States of America
Listing US SLS

About SELLAS Life Sciences Group, Inc.

https://www.sellaslifesciences.com/

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's core activity involves advancing its pipeline of cancer immunotherapies, which are designed to utilize the patient's immune system to combat various malignancies. Its development programs aim to address significant unmet medical needs in oncology by creating new treatment options for cancer patients.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing financial results for the year ended December 31, 2011, and that the press release is attached as Exhibit 99.1. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 2913 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and states that a report or press release is attached or published, it should be classified as a Regulatory Filing (RNS) rather than the report itself (like 10-K or ER). Therefore, this document is best classified as a Regulatory Filing (RNS).
2012-03-28 English
FORM 8-K
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes legal proceedings involving the company, specifically lawsuits related to warrant repurchase demands and related payments. There is no detailed financial data or comprehensive report content, but rather an update on legal matters. This fits the category of Legal Proceedings Report (LTR). The document length is 3147 characters, which is short and focused on a specific event, consistent with an 8-K filing about legal proceedings rather than a full annual or quarterly report or other categories.
2012-03-28 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes an entry into a material definitive agreement (an amendment to a securities purchase agreement) and an announcement of a conditional dividend distribution of subsidiary shares. There are no financial statements or detailed financial performance data present, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a call transcript, proxy statement, or remuneration report. The document is primarily an announcement of corporate events related to financing and dividend distribution. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters but contains substantive event details rather than just a report publication announcement. Confidence is high due to clear identification of financing agreement amendment and dividend declaration.
2012-03-07 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated March 5, 2012, by Galena Biopharma, Inc. The content specifically reports that the company has regained compliance with NASDAQ listing requirements by meeting the minimum bid price rule. This is a regulatory announcement about the company's stock listing status, not a full financial report, earnings release, or management discussion. The document is short (2101 characters) and focuses on a compliance update related to stock listing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2012-03-05 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about a Controlled Equity Offering sales agreement, amendments to agreements, legal proceedings updates, and other corporate events. There are no comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). The document primarily announces material definitive agreements, amendments, and legal updates, which are typical contents of an 8-K filing. The document is not a transcript, earnings release, or proxy statement. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2012-02-17 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It details a controlled equity offering of common stock, including terms of the offering, use of proceeds, risk factors, and other related information. It is a registration statement supplementing a shelf registration, describing a capital raising transaction. The document is not a financial report, earnings release, or management discussion, but rather a detailed disclosure related to a financing activity. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual offering document, not just an announcement or a brief summary.
2012-02-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.